logo

News

    • 3RD APRIL 2025

    SSP for Estradot® 25micrograms/24hours patch issued

    In response to a significant ongoing disruption to the supply of Estradot® 25micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 3rd April 2025, SSP082, provides that for every Estradot® 25micrograms/24hours patch originally prescribed either one Evorel® 25 patch or one Estraderm® MX

    Read more
    • 3RD APRIL 2025

    April 2025 Category M prices announced

    The Drug Tariff Category M pricelist for April 2025 has been published on the NHS Business Services Authority (NHSBSA) website. This price list includes a margin increase of +£12.3m per quarter, as the result of the CPCF settlement announced for 2024/25 and 2025/26. Without the agreed uplifts included in the settlement, the margin adjustment would have

    Read more
    • 2ND APRIL 2025

    MHRA Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution

    MHRA Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution Drug Alert Number: EL(25)A/14 Date issued: 02 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Urospir 50mg/5ml Oral Solution DMRC reference number: DMRC-35150350 Marketing Authorisation Holder:Rosemont Pharmaceuticals Ltd Product name: Urospir 50mg/5ml Oral Solution SNOMED code:

    Read more
    • 2ND APRIL 2025

    April 2025 Drug Tariff updates

    The NHS Business Services Authority (NHSBSA) has published updates to the April Drug Tariff to include details from the CPCF arrangements for 2025/26. These updates can be found on the NHSBSA website here and include the following: Part I – Changes to the Payment Timetable to include earlier fee payments for the Hypertension Case Finding Service

    Read more
    • 1ST APRIL 2025

    Rolled over price concessions for April 2025

    The following price concessions granted in March 2025 have rolled over to April 2025: Drug Pack size March 2025 price concession Fusidic acid 1% modified-release eye drops 5 £21.00 Oxybutynin 2.5mg tablets 56 £1.11 Timolol 0.5% eye drops 5 £1.63 Venlafaxine 300mg modified-release tablets 30 £43.09 Please note any rolled over prices can be adjusted

    Read more
© 2025 Middlesex Pharmaceutical Group